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BACKGROUND: Kindler Syndrome (KS) is a rare genodermatosis characterized by
skin fragility, skin atrophy, premature aging and poikiloderma. It is caused by
mutations in the FERMT1 gene, which encodes kindlin-1, a protein involved in
integrin signalling and the formation of focal adhesions. Several reports have shown
the presence of non-melanoma skin cancers in KS patients but a systematic study
evaluating the risk of these tumors at different ages and their potential outcome has
not yet been published. We have here addressed this condition in a retrospective
study of 91 adult KS patients, characterizing frequency, metastatic potential and
body distribution of squamous cell carcinoma (SCC) in these patients. SCC developed
in 13 of the 91 patients.
RESULTS: The youngest case arose in a 29-year-old patient; however, the cumulative
risk of SCC increased to 66.7% in patients over 60 years of age. The highly
aggressive nature of SCCs in KS was confirmed showing that 53.8% of the patients
bearing SCCs develop metastatic disease. Our data also showed there are no specific
mutations that correlate directly with the development of SCC; however, the
mutational distribution along the gene appears to be different in patients bearing
SCC from SCC-free patients. The body distribution of the tumor appearance was also
unique and different from other bullous diseases, being concentrated in the hands
and around the oral cavity, which are areas of high inflammation in this disease.
CONCLUSIONS: This study characterizes SCCs in the largest series of KS patients
reported so far, showing the high frequency and aggressiveness of these tumors. It
also describes their particular body distribution and their relationship with mutations
in the FERMT-1 gene. These data reinforce the need for close monitoring of
premalignant or malignant lesions in KS patients.
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